© 2026 WYSO
Our Community. Our Nation. Our World.
Play Live Radio
Next Up:
0:00
0:00
0:00 0:00
Available On Air Stations
NPR Health

Moderna and Merck's mRNA vaccine reduces melanoma recurrence by 42%

Moderna and Merck recently released remarkable new results of their personalized cancer vaccine.

Here & Now‘s Scott Tong speaks with Matthew Herper, a senior writer at STAT, the health and science publication.

This article was originally published on WBUR.org.

Copyright 2026 WBUR

NPR Health